Virtu Financial’s Ensysce Biosciences ENSC Stock Holding History

Virtu Financial’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7K	Buy	+13,313	New	+$8.44K	﹤0.01%	1481
2025 Q4	–	Sell	-14,222	Closed	-$34K	–	1808
2025 Q3	$34K	Buy	+14,222	New	+$30.6K	﹤0.01%	1199
2024 Q3	–	Sell	-756	Closed	-$6K	–	1508
2024 Q2	$6K	Buy	+756	New	+$6.89K	﹤0.01%	1172
2023 Q2	–	Sell	-896	Closed	-$65K	–	1654
2023 Q1	$65K	Buy	+896	New	+$103K	0.01%	1057
2022 Q4	–	Sell	-12	Closed	-$9K	–	1758
2022 Q3	$9K	Buy	+12	New	+$19.6K	﹤0.01%	1530
2022 Q2	–	Sell	-7	Closed	-$28K	–	1707
2022 Q1	$28K	Buy	+7	New	+$46.3K	﹤0.01%	1249
2021 Q4	–	Sell	-7	Closed	-$78K	–	1844
2021 Q3	$78K	Buy	+7	New	+$137K	0.01%	1201

Other funds holding ENSC

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TIAM2

Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's ENSC Position: Q1 2026 in Review

Virtu Financial opened a new position in Ensysce Biosciences (ENSC) in Q1 2026: 13,313 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ENSC as recently as Q3 2025.

Virtu Financial first reported a position in ENSC in Q3 2021 and has held it in 7 quarters since. The position peaked at $78K in Q3 2021. 15 funds tracked by Wall St. Rank hold ENSC as of Q1 2026.

Virtu Financial held 13,313 shares of Ensysce Biosciences worth $7K as of Q1 2026.
Ensysce Biosciences was a new Virtu Financial position in Q1 2026.
Ensysce Biosciences made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1481 holding.
Virtu Financial first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 7 quarters since.
Virtu Financial's Ensysce Biosciences position peaked at $78K in Q3 2021.
15 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.